Received government funding or funding expected in current financial year
No
Business Relationships
Amylyx Pharmaceuticals Inc. is not a subsidiary of any other parent companies.
Amylyx Pharmaceuticals Inc. is not a coalition.
Beneficiaries of the Lobbying Activity
The activities of Amylyx Pharmaceuticals Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Amylyx Pharmaceuticals Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
What is being lobbied?
Subject Matters
Health
Subject Matter Details
Policies or Program
Engage with government on timely and equitable access to new therapies for patients with Amyotrophic lateral sclerosis (ALS), including finding solutions to early access to new ALS therapies for patients.
Who is being lobbied?
Government Institutions
Health Canada (HC)
House of Commons
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Communication techniques
Communication techniques that have been used or are expected to be used in the course of the undertaking: